INS and type 2 diabetes mellitus: T2DM phenotype in SSA has been characterized by early onset in a younger population (<50 years) [15] and pancreatic beta-cell secretory dysfunction which manifests as the blunted acute first phase of insulin secretion rather than peripheral insulin resistance [16, 17].